English
Home > Products > pyran-4-yl)amino)pyrazine-2-carbonitrile

China pyran-4-yl)amino)pyrazine-2-carbonitrile Factory

Our commission should be to provide our end users and clients with very best excellent and aggressive portable digital products and solutions for pyran-4-yl)amino)pyrazine-2-carbonitrile,CAS NO 2043019-98-1,2043019-98-1,Gilteritinib intermediate,Gilteritinib advance intermediate, We will do our greatest to meet or exceed customers' demands with top quality items, advanced concept, and productive and timely company. We welcome all customers.
pyran-4-yl)amino)pyrazine-2-carbonitrile, We've been confident that we are able to offer you with opportunities and might be a valuable business partner of you. We look forward to working with you soon. Learn more about the types of merchandise that we work with or contact us now directly with your inquiries. You are welcome to contact us anytime!

Related Products

Hot Products

  • Rifampicin Capsules

    Rifampicin Capsules

    Product Name:Rifampicin Capsules
    Dosage:0.15g
    Application:Antibiotic
  • Dinoprost Trometamol

    Dinoprost Trometamol

    Product Name:Dinoprost Trometamol
    Molecular Formula:C24H45NO8
    Molecular Weight:475.62
    CAS Registry Number:38562-01-5
  • Ensartinib

    Ensartinib

    Product Name:Ensartinib
    Molecular Formula:C25H25Cl2FN6O3
    Molecular Weight;547.41
    CAS Registry Number;1365267-27-1
  • Cloxacillin benzathine

    Cloxacillin benzathine

    Product Name:Cloxacillin benzathine
    Molecular Formula:C35H38ClN5O5S
    Molecular Weight;676.23
    CAS Registry Number;23736-58-5
  • Alogliptin benzoate

    Alogliptin benzoate

    Product Name:Alogliptin benzoate
    Molecular Formula:C25H27N5O4
    Molecular Weight;461.52
    CAS Registry Number;850649-62-6
  • Polaprezinc

    Polaprezinc

    Product Name:Polaprezinc
    Molecular Formula:C9H12N4O3Zn
    Molecular Weight;289.61
    CAS Registry Number;107667-60-7
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept